Work

External validation and updating of NTCP models for radiation pneumonitis: QUANTEC, Appelt, and a local simplified model

Year: 2026

Type: article

Abstract: Objective: To externally evaluate and update the QUANTEC and Appelt NTCP models for radiation pneumonitis (RP) in lung cancer patients treated with contemporary IMRT and multimodal therapy, and to preliminarily validate a simplified local model in an independent cohort. Methods: We retrospectively analyzed 580 lung cancer patients treated with thoracic IMRT between 2018 and 2023 as the development cohort. The QUANTEC and Appelt models were evaluated and locally updated using a closed testing procedure to determine the least extensive revision required. Clinical and DVH variables were standardized, and smoking status and pulmonary comorbidity were recoded according to published definitions. A final simplified local model (Model D) was developed using BIC-guided multivariable logistic regression with regularization. Performance was assessed by AUC, Brier score, calibration-in-the-large (CITL), calibration slope, Hosmer-Lemeshow test, and decision curve analysis. External validation of Model D was performed in 100 patients from an independent center using fixed coefficients. Results: Both the QUANTEC and Appelt models showed substantial calibration bias in the local cohort, with systematic underestimation of RP risk. Updating improved calibration as expected, with little change in discrimination. Model D, incorporating age, stage, smoking status, tumor location, pulmonary comorbidity, NLR, SII, V30, and MLD, showed the best apparent overall performance in the development cohort (AUC 0.708, Brier 0.215, CITL = 0, slope = 1, Hosmer-Lemeshow P = 0.599). In the external cohort, discrimination and prediction error were similar (AUC 0.718, 95% CI 0.576-0.831; Brier 0.207), although absolute RP risk was overestimated (CITL = -1.043, slope = 1.133, Hosmer-Lemeshow P < 0.001). Conclusions: The original QUANTEC and Appelt models underestimated RP risk in this contemporary IMRT cohort. Updating improved calibration, whereas discrimination changed little. Model D showed better apparent overall performance and preserved ranking ability in an independent external cohort. Calibration drift across centers suggests that simple recalibration may improve absolute risk estimation in new settings. Clinical trial registration: https://www.chictr.org.cn/hvshowproject.html?id=276191&v=1.1, identifier ChiCTR2500102055.

Source: Frontiers in Oncology

DOI: 10.3389/fonc.2026.1777999